These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20006873)

  • 1. Editorial comment.
    Suardi N
    J Urol; 2010 Feb; 183(2):545. PubMed ID: 20006873
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?
    Ploussard G; Salomon L; Xylinas E; Allory Y; Vordos D; Hoznek A; Abbou CC; de la Taille A
    J Urol; 2010 Feb; 183(2):539-44. PubMed ID: 20006888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment on: Prostate-specific antigen improves the ability of clinical stage and biopsy gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
    Stenman UH
    Eur Urol; 2007 Oct; 52(4):1074-5. PubMed ID: 17383813
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment on: systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
    Greene DR
    Eur Urol; 2007 Sep; 52(3):744-5. PubMed ID: 17350749
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment on: systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
    Trpkov K
    Eur Urol; 2007 Sep; 52(3):743-4. PubMed ID: 17350751
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment.
    Carter HB
    Urology; 2009 Sep; 74(3):658; author reply 659. PubMed ID: 19716923
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment.
    Mann MJ
    J Urol; 2010 Mar; 183(3):1009. PubMed ID: 20092841
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment.
    Vollmer RT
    J Urol; 2010 Mar; 183(3):1001-2. PubMed ID: 20089267
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment.
    Epstein JI
    J Urol; 2010 Mar; 183(3):1001. PubMed ID: 20089268
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment.
    Pfitzenmaier J
    J Urol; 2010 Mar; 183(3):1009. PubMed ID: 20092832
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment.
    Makarov DV
    J Urol; 2009 Nov; 182(5):2255-6. PubMed ID: 19758643
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment.
    Naselli A
    J Urol; 2009 Nov; 182(5):2256. PubMed ID: 19758664
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
    van der Poel HG
    Eur Urol; 2008 Mar; 53(3):561-2. PubMed ID: 17683855
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment.
    Nguyen PL
    J Urol; 2010 Mar; 183(3):989. PubMed ID: 20083273
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial comment.
    Moul JW
    Urology; 2010 Feb; 75(2):445-6; author reply 446. PubMed ID: 20152507
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment.
    Slawin KM
    Urology; 2010 Feb; 75(2):444-5; author reply 445. PubMed ID: 20152505
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment.
    van Renterghem KM
    J Urol; 2009 Oct; 182(4):1349; discussion 1349. PubMed ID: 19683263
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment.
    Lin CC
    J Urol; 2009 Oct; 182(4):1348; discussion 1349. PubMed ID: 19683264
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment.
    Chong KT
    J Urol; 2009 Oct; 182(4):1348; discussion 1349. PubMed ID: 19683273
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment on: prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review.
    Rittmaster R
    Eur Urol; 2008 Sep; 54(3):514-5. PubMed ID: 18585846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.